Suppression of the disulfidptosis ameliorates NiONPs-induced collagen deposition by hsa_circ_0007702/miR-181d-5p/SLC7A11 axis

The lungs are designed to be flexible, expanding and contracting with every breath to exchange oxygen for carbon dioxide. But when this delicate tissue is damaged by chronic inflammation or toxic particles, the body sometimes overreacts. Instead of healing cleanly, it lays down thick, stiff scar tissue, a condition known as pulmonary fibrosis. This scarring makes the lungs rigid and unable to function, slowly suffocating the patient. While scientists have long known that certain industrial pollutants can trigger this process, the precise molecular switches that flip the body from healing to scarring have remained largely hidden. Recently, researchers have begun to look at a specific type of cell death called disulfidptosis. Unlike the more familiar forms of cell death, this process occurs when a cell's internal energy supply runs out while it is trying to manage a specific type of chemical stress, causing the cell's structural skeleton to collapse. Understanding how toxic particles might hijack this mechanism to cause scarring could reveal new ways to stop the disease before it becomes irreversible.

A team of researchers at Lanzhou University and affiliated hospitals in China has now connected these dots, showing how exposure to nickel oxide nanoparticles, a common industrial pollutant, drives this specific type of cell death to cause lung scarring. Nickel oxide nanoparticles are tiny particles, averaging just 20 nanometers in size, used widely in electronics and manufacturing. When inhaled, they can settle deep in the lungs. The researchers wanted to know exactly how these particles turn healthy lung cells into scar-forming factories. They focused on a chain of molecular events involving a specific protein transporter, a small regulatory RNA molecule, and a circular RNA molecule that acts as a sponge. By studying both rats exposed to the particles and human lung cells in a lab, they traced the path from the initial chemical insult to the final buildup of collagen, the main component of scar tissue.

The investigation began by exposing human lung cells to nickel oxide nanoparticles. The researchers observed that the particles caused the cells to produce excessive amounts of a protein called SLC7A11. This protein acts as a gatekeeper, allowing certain nutrients to enter the cell while blocking others. Under normal conditions, this gate helps the cell survive, but when it is forced open too wide by the nanoparticles, it creates a dangerous imbalance. The cells began to consume their internal energy reserves at a frantic rate, leading to a state where they could no longer maintain their structural integrity. This energy crisis triggered disulfidptosis, a process where the cell's internal scaffolding, made of actin filaments, suddenly snapped and crumbled. As the cells died and their structure failed, they sent out signals that caused neighboring cells to produce massive amounts of collagen, leading to the stiffening and scarring characteristic of fibrosis.

To confirm that this energy crisis and structural collapse were the true culprits, the scientists intervened in the process. They used a chemical agent known to prevent the specific type of cell death they were observing. When they applied this agent to the cells exposed to the nanoparticles, the cells did not suffer the same structural collapse. Instead of breaking down, the cells maintained their shape, and the production of scar tissue dropped significantly. This proved that stopping the disulfidptosis process directly reduced the scarring. The researchers then took a closer look at the protein SLC7A11, the gatekeeper that seemed to be driving the problem. When they used genetic tools to lower the amount of this protein in the cells, the same protective effect occurred. The cells survived the exposure, their internal energy levels remained stable, and the excessive collagen production ceased. This confirmed that the overactive SLC7A11 protein was the primary engine driving the scarring process.

The story, however, did not end with the protein itself. The researchers needed to understand what was telling the cell to produce so much SLC7A11 in the first place. They discovered that the nanoparticles were triggering a rise in a specific circular RNA molecule, named hsa_circ_0007702. In the world of cell biology, these circular RNAs often act like sponges, soaking up other molecules that would normally suppress gene activity. In this case, the circular RNA was soaking up a small regulatory molecule called miR-181d-5p. Normally, this small molecule would keep the levels of the SLC7A11 protein in check. But when the circular RNA sponge absorbed it, the small molecule could no longer do its job, allowing SLC7A11 to run wild. The researchers tested this by removing the circular RNA sponge from the cells. Without the sponge, the small regulatory molecule was free to function again, it suppressed the SLC7A11 protein, and the cells were protected from the damaging effects of the nanoparticles.

This entire chain of events forms a clear line of cause and effect. The nickel oxide nanoparticles enter the lung and increase the levels of the circular RNA sponge. This sponge mops up the protective regulatory molecule, which in turn allows the SLC7A11 protein to become overactive. The overactive protein drains the cell's energy, causing the internal skeleton to collapse in a process called disulfidptosis. This collapse signals the tissue to lay down thick layers of scar tissue. The researchers found that breaking any link in this chain—by removing the circular RNA, adding back the regulatory molecule, or blocking the SLC7A11 protein—stopped the scarring. They also confirmed these findings in a rat model, where the same molecular changes were observed in the lung tissue of animals exposed to the nanoparticles.

The study suggests that the key to preventing this specific type of lung damage lies in interrupting this molecular pathway. By targeting the circular RNA or the protein it helps to activate, it might be possible to stop the cell death and subsequent scarring before it takes hold. While the research was conducted in controlled laboratory settings and animal models, it provides a detailed map of how a common industrial pollutant can hijack a specific cell death mechanism to cause disease. The findings offer a new perspective on pulmonary fibrosis, moving beyond general inflammation to pinpoint a precise metabolic failure. This clarity could eventually lead to therapies that protect the lungs by preserving the cell's energy balance and structural integrity, offering hope for those exposed to hazardous nanoparticles in the future.